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ABSTRACT  
 
Background/ aims: To compare the accuracy of self-, partner-, and trainer-obtained 
measurements using the handheld Icare Home rebound tonometer with Goldmann 
applanation tonometry (GAT), and to evaluate the acceptability to subjects of Icare 
Home measurement.  
 
Methods: 76 subjects were trained to use Icare Home for self-measurement using a 
standardised protocol.  A pre-specified checklist was used to assess the ability of a 
subject to perform self-tonometry. Accuracy of Icare Home self-measurement was 
compared with GAT using one eye per subject, randomly selected. Bland-Altman 
difference analysis was used to compare Icare Home and GAT intraocular pressure 
(IOP) estimates. Acceptability of self-tonometry was evaluated using a questionnaire. 
 
Results: 56 subjects (74%, 95%CI 64-84) were able to correctly perform self-
tonometry. Mean bias (95% limits of agreement) was 0.3mmHg (-4.6 to 5.2), 
1.1mmHg (-3.2 to 5.3), and 1.2mmHg (-3.9 to 6.3) for self-, partner-, and trainer-
assessment respectively, suggesting underestimation of IOP by Icare Home 
tonometry. Differences between GAT and Icare Home IOP were greater for CCT 
below 500µm and above 600µm than data points within this range. Acceptability 
questionnaire responses showed high agreement that the self-pressure device was 
easy to use (84%), the reading was quick to obtain (88%) and the measurement was 
comfortable (95%).  
 
Conclusion: Icare Home tonometry can be used for self-measurement by a majority 
of trained subjects.  IOP measurements obtained using Icare Home tonometry by 
self- and third party-assessment showed slight underestimation compared with GAT.  
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INTRODUCTION 
 
The measurement of intraocular pressure (IOP) is essential in management of the 
glaucomas. Elevated and fluctuating IOP are risk factors for the development and 
progression of primary open angle glaucoma (OAG).[1-4] IOP remains the principal 
risk factor modified in the treatment of OAG.   
 
IOP assessment is subject to variability, and measurement error may contribute 
considerably to misclassification. Using data from the Blue Mountains Eye Study, it 
was shown that 34% of individuals with ocular hypertension (OHT) would be missed 
using a tonometer that underestimated IOP by 1mmHg. Conversely, 58% false 
positive screening tests would occur using a tonometer that over-read by 1mmHg.[5] 
Within-subject variation may also contribute. In the Barbados Eye Study, a sample of 
2856 individuals without glaucoma or suspected glaucoma were re-examined on a 
separate occasion. Of the 361 subjects who were receiving treatment or had an IOP 
>21mmHg at baseline, 30% had IOP 21mmHg on repeat assessment.[6]  
 
Diurnal variations in IOP occur in normal subjects,[7, 8] and can be exaggerated in 
patients with glaucoma.[9] A study of glaucoma subjects admitted for 24-hour 
monitoring found that 52% of peak IOP values were recorded outside office hours, 
resulting in a change in clinical management for 23 participants (79%).[10] 
Repeating IOP measurements over the course of a day is typically limited to office 
hours and can be impractical in a busy clinic setting. An alternative option is for 
patients to monitor their own IOP. This concept has become a real possibility with 
the development of home tonometers that do not require the use of topical 
anaesthesia. The value of home monitoring by patients has long been recognised in 
the diagnosis and management of systemic hypertension.[11]  
 
This study evaluates the performance of the Icare Home, a hand-held tonometer 
designed for self-use. The tonometer uses the same rebound technology of Icare 
One (preceding model), but integrates EyeSmart eye recognition and EasyPos 
alignment features to improve use-ability. IOP is determined by impact duration or 
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deceleration of a magnetic solenoid probe directed at the central cornea[12], and 
computed from 6 consecutive measurements. The Icare One has shown good 
agreement with the current reference standard Goldmann Applanation Tonometer 
(GAT) when used for self-measurement by adults,[13-16] and by a caregiver on a 
child.[17] The device has also demonstrated good repeatability.[13], [16]  
 
The Icare Home tonometer has been recently released and, to date, a single 
abstract reports the accuracy of IOP estimates using this machine. This study aimed 
to determine the proportion of subjects who may be taught to obtain a measure of 
their IOP using the Icare Home tonometer, to undertake a methods comparison 
study with GAT, and determine the acceptability of the device to subjects. A 
secondary aim was to assess the feasibility of third party IOP measurement using 
the Icare Home tonometer.     
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MATERIALS AND METHODS 
 
The study had institutional review board approval from the School of Health 
Sciences Research and Ethics Committee, City University London.  All subjects 
provided informed consent and the study adhered to the tenets of the Declaration of 
Helsinki. Subjects aged 18 years and older were recruited from clinics, and via a 
request for volunteers in an International Glaucoma Association newsletter. 
Exclusion criteria were anomalies of the anterior segment which affect corneal 
integrity, and those unable to speak fluent English.  
 
A standardised training protocol for Icare Home tonometry was developed using 
manufacturers’ recommendations.[18] The training process is illustrated in Figure 1 
and described in more detail in online supplementary Figure S1. IOP data are saved 
in the tonometry memory by date, time, and measured eye. They can only be viewed 
by download to a computer. Unreliable measurements with a high standard deviation 
were excluded for analysis. Icare data were acquired without the use of topical 
anaesthesia.  
 
Details of hand dominance and self-reported dexterity, contact lens wear, refractive 
error and corneal astigmatism (Topcon KR 8000), vertical palpebral aperture (VPA), 
and visual acuity (computerised logMAR) were obtained. Each subject was 
instructed on proper use of Icare Home self-tonometry with their dominant hand and 
by a single experienced trainer. Once confident with use of the device, the subject 
was asked to obtain 3 reliable IOP measurements of each eye (right first). The 
subject was classified as being able to perform self-tonometry if four criteria 
amended from manufacturers’ guidelines[18] were satisfied: 
1) The median of three IOP measurements by the trainer and subject differ by 
5mmHg. 
2) For IOP readings between 7-23mmHg the range of three measurements by 
the subject is 5mmHg, and 7mmHg for IOP readings >23mmHg. 
3) The positioning of the tonometer by the subject is correct as judged by the 
trainer.  
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4) The subject took 30 minutes from the start of training to obtain 3 reliable IOP 
measurements of each eye without trainer interaction 
 
GAT was performed following all Icare Home measurements. The clinician was 
masked to Icare Home results. A median of three recordings was used for 
analysis.[19] The dial was set to 10mmHg between readings, and not observed until 
the end-point had been determined. GAT and comparison self-tonometry 
measurements were performed within a 15-minute period. Central corneal thickness 
(CCT) (Accutome Pachpen) was then determined from the mean of nine 
measurements. Finally, each subject was asked to complete a questionnaire 
comprising 5-point Likert scales to score the acceptability of Icare Home tonometry.  
 
The secondary aim of this study was to determine whether an accompanying person 
could be taught to use the Icare Home.  Following consent, the accompanying 
person underwent the training procedure described in Figure 1. Their ability to 
perform Icare Home tonometry on the primary subject was assessed against the 
four-point checklist above. 
 
Sample size 
Based on Icare One it was anticipated that 75% of subjects would potentially be able 
to perform self-tonometry.[14] A sample size of 75 would demonstrate this proportion 
±10% with 95% confidence. For a standard deviation of the mean difference in 
measurements of 2.7mmHg between Icare One and GAT,[14] a sample size of 56 
(75% of 75) would demonstrate agreement between instruments of ±1.2mmHg with 
95% confidence.[20]  
 
Analysis 
Icare Home measurements were downloaded using iLink software and statistical 
analysis was performed using SPSS 22.0 software (www.ibm.com/SPSS_Statistics). 
Based on a pilot study, a decision was made to use a median of three Icare Home 
IOP measurements of a given eye for analysis in place of a single reading. 
Demographic characteristics were compared between subject groups using 
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parametric or non-parametric statistical tests as appropriate. The chi-squared test 
was used to compare categorical variables. For all tests, P<0.05 was considered 
statistically significant.  
 
Using data from a randomly selected eye, Bland-Altman analysis was used to 
examine consistent bias between IOP measurements by Icare Home tonometry and 
reference standard GAT and to plot the variability about this difference. The upper 
and lower 95% limits of agreement represented the mean difference between the 
devices ±1.96 SD of the differences between data sets.  
 
Responses to the user acceptability survey using Likert scales were aggregated into 
summary tables. Free-text responses were coded and assigned to categorical 
variables.    
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RESULTS 
 
76 subjects (N=42, 55% female) entered the study. Their median age was 68 years 
(interquartile range 55-81). On self-reported history, 49 (65%) had OAG, 9 (12%) 
angle closure glaucoma, 4 (5%) ocular hypertension and 14 (18%) no glaucoma 
related diagnosis. The majority (N=69, 91%) were right hand dominant, and 18 
(24%) reported problems with hand mobility/ dexterity (e.g. arthritis, tremor) in their 
dominant hand. A summary of clinical measurements is provided in Table 1.  
 
Measurement Mean +/- SD 
Visual acuity (logMAR) 0.2±0.5 
Mean refractive error (DS) -0.8±4.1 
Corneal astigmatism (DC) -0.9±0.9 
Vertical palpebral aperture (mm) 9.8±1.6 
CCT (µm) 540.4±43.1 
GAT (mmHg) 15.4±5.0 
Icare Home – self (mmHg)* 15.1±5.9 
Icare Home – trainer (mmHg)* 14.2±5.9 
Table 1: A summary of clinical measurements representing data from the 
randomly selected eye from subjects in the tonometry methods comparison 
study.  
*  Results for the 56 subjects able to perform self-tonometry using Icare Home 
 
56 subjects (74%, 95%CI 64-84) were able to correctly perform self-tonometry 
(41/58 (71%) with glaucoma, 15/18 (83%) without glaucoma, Chi2 p=0.3). Of the 20 
subjects who were unable to perform the technique, 12 (60%) positioned the probe 
incorrectly at the central cornea, 4 (20%) handled the device poorly, and 4 (20%) 
failed to meet IOP validation criteria. The mean time taken from the start of training 
to being able to reliably obtain 3 measurements of each eye without trainer 
interaction was 21 minutes (SD 5, range 11 to 30 minutes). 
 
No association was observed between a subjects’ ability to perform self-tonometry 
and gender (p=0.1), previous or current contact lens wear (p=0.1), hand-dexterity 
(p=0.7), educational level (p=0.3), refractive error (p=0.3) or vertical palpebral 
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aperture (p=0.3). Of the 5 subjects who measured a visual acuity of 1.0 logMAR 
(6/60 Snellen equivalent) or less in one or both eyes, 3 were unable to perform self-
tonometry. 
 
21 accompanying persons (N=4, 19% female, median age 69 years (interquartile 
range 56 to 82 years)) underwent Icare Home partner-training. 18 (86%, 95% CI 71 
to 100) correctly performed Icare Home tonometry taking a mean time of 19 minutes 
(SD 4, range 12 to 25 minutes) from the start of training to obtain 3 reliable 
measurements of each eye. Of the 3 subjects who failed to perform partner-
tonometry correctly; 2 had poor positioning and 1 failed to satisfy the validation 
criteria. 2 of the 21 subjects reported problems with mobility in their dominant hand; 
one with a mild hand tremor succeeded in partner-tonometry, but the other with mild 
arthritis failed to correctly perform the technique. Of the six subjects unable to 
correctly perform Icare Home self-tonometry, 3 had accompanying persons who 
adequately completed partner-tonometry. 
 
Bland-Altman plots comparing Icare Home and GAT are shown in Figure 2. There is 
a systematic tendency for the Icare Home tonometer to slightly underestimate IOP. 
The least mean bias was in self-tonometry (underestimate 0.3mmHg (95% limits of 
agreement -4.6 to 5.2). Measurement by the trainer and partner had similar bias of 
1.2mmHg (-3.9 to 6.3) and 1.1mmHg (-3.2 to 5.3) respectively. The difference 
between self and third party Icare Home measurement error was significant (t-test, 
p=0.003).  
 
The Icare Home operating manual notes that the device has not been validated for 
CCT outside the range of 500-600µm and corneal astigmatism >3DC.[18] The 
measurement error was examined using this CCT cut-off and suggested a greater 
systematic difference outside of this reference range (Table 2). This was also the 
case for three subjects with corneal astigmatism >3DC (mean underestimation 
2mmHg). No pattern was observed between the difference in self-Icare Home 
measurements and GAT tonometry by age, mean spherical equivalent, visual acuity, 
VPA, and baseline GAT. Mean differences between Icare Home and GAT revealed 
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greater under-estimation for the right eye compared with the left eye in all three 
observers; trainer (R 1.7, L 0.7mmHg), self (R 0.6 L 0.0mmHg) and partner (R 1.6 L 
1.0mmHg).  
 
Central corneal 
thickness (CCT)  
(µm) 
N (%) 
Mean difference GAT/ 
Self-Icare Home IOP 
(mmHg) 
<500µm 8 (14.3) 1.9 (SD 1.7) 
500-600µm 43 (76.8) -0.1 (SD 2.6) 
>600µm 5 (8.9) 1.0 (SD 1.7) 
Table 2: Mean IOP difference between GAT and self-Icare Home tonometry by 
central corneal thickness (CCT) 
 
All subjects who entered the study completed the acceptability survey. Five of the 20 
subjects who failed to perform self-measurements were aware of this performance 
outcome. Responses to the survey are summarised in Table 3. A greater proportion 
of subjects able to perform self-tonometry reported the device as easy to use, quick, 
comfortable, and were willing to use Icare Home again. Free text comments included 
23 noting problems aligning the device, of which 7 referred to difficulty in viewing the 
green indicator base light when performing self-measurement, particularly in an eye 
with poorer vision or more extensive glaucomatous visual field loss. A further 6 
subjects commented on problems opening the measurement probe container, and 
positioning the probe in the device to obtain a measurement. 3 subjects suggested 
modification of the device to improve use-ability such as an auditory indicator to 
determine correct positioning. 
 
Statement 
Agree N (%) 
Self-tonometry Partner-tonometry 
Able to 
perform 
tonometry 
Unable to 
perform 
tonometry 
All 
subjects  
Able to 
perform 
tonometry 
Unable to 
perform 
tonometry 
All 
subjects  
The self-pressure 
device was easy to 
use 
52 (93) 12 (60) 64 (84) 16 (89) 3 (100) 19 (90) 
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The reading was 
quick to obtain 53 (95) 14 (70) 67 (88) 18 (100) 3 (100) 21 (100) 
The measurement 
was comfortable 55 (98) 17 (85) 72 (95) --- --- --- 
I would use this 
device again 55 (98) 14 (70) 69 (91) 17 (94) 3 (100) 20 (95) 
I would use this 
device at home 55 (98) 14 (70) 69 (91) 18 (100) 3 (100) 21 (100) 
Table 3:  Aggregated Likert scale responses to Icare Home self- and 
partner-measurement acceptability in response to five statements 
 
Of the 21 accompanying persons who took part in the study, over 90% had positive 
views about the device (Table 3). The majority of negative comments made 
reference to difficulties in aligning the device at the cornea.    
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DISCUSSION 
 
The ideal self-tonometer needs to be safe, reliable, reproducible, easy to use, and 
accurate over a wide range of IOP measurements. The present study has shown 
that the Icare Home rebound tonometer was useable by three quarters (78%) of 
subjects (self-measurement or assessment by a partner), demonstrated reasonable 
agreement with reference standard GAT, and was well received by a predominantly 
older population.  
 
Comparisons with previous literature are largely based on reports of the preceding 
model (Icare one). A study of 126 subjects observed a similar proportion (75%) able 
to perform self-tonometry using the Icare One,[14] although two later reports found 
higher patient success rates of 99%[15] and 100%.[16] However, both studies 
sampled a younger population with a lower proportion of subjects with glaucoma. 
Furthermore, the methods used to evaluate a subjects’ ability to perform self-
tonometry were not outlined in previous reports, and the manual for the Icare One 
tonometer does not include validation criteria.[21] Our study suggested that 
individuals with poor vision were more likely to have difficulties performing self-
tonometry. Following this observation, subjects with Humphrey Field Analyzer mean 
deviation (MD) of -6dB or better were compared with those with MD worse than -
6dB. 8 of 33 (24%) with a good MD compared to 5/13 (38%) with a poor MD were 
unable to perform self-tonometry. This did not represent a statistically significant 
difference (Chi2 p=0.3). Subjects with glaucoma had a mean MD of -8.04±9.40dB. 
No pattern was observed between glaucoma severity and ability to perform self-
tonometry. 
 
A 2012 systematic review on the accuracy of tonometers available in clinical practice 
suggested that non-contact tonometry showed the least variability. Two thirds of non-
contact tonometry readings were within 2mmHg of GAT, compared with 52% of 
rebound tonometry measurements.[22] The present study found that 66% and 84% 
of Icare Home self-measurements were within 2mmHg and 3mmHg of GAT 
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respectively, comparing well with previous reports of self-use by Icare One (56% 
within 2mmHg,[13] 67%[15] and 63%[16] within 3mmHg). 
 
Overall, the Icare Home tonometer generated slightly lower IOP measurements to 
GAT. This difference was smaller with self-measurement (0.3mmHg) than with third 
party assessment (1.1-1.2mmHg). We found a single conference abstract evaluating 
the Icare Home, which also reported underestimation of IOP measurements (mean 
bias 0.95mmHg).[23] Furthermore, the authors observed greater underestimation of 
Icare Home measurements when used by an ophthalmologist than compared with 
self-measurement (mean under-read 0.21mmHg). This observation may be due to 
apprehension and eye squeezing during self-measurement resulting in an artefactual 
rise in IOP.  It may also be a result of poorer positioning and angling of the probe at 
the central cornea.[24] The majority of previous comparisons between Icare One and 
GAT demonstrate overestimation of self-readings with the largest mean difference 
being 2.3mmHg.[14-16] Icare One and Icare Home tonometers use the same 
rebound technology but the updated model integrates features that may influence 
the accuracy of measurements. An earlier report observing similar underestimation 
of self-measurement using Icare One tonometry also found a negative correlation 
between subject age and GAT-Icare One differences. This raises the suggestion that 
discrepancies between our study results and those using previous Icare models may 
also be attributed to characteristics of the populations studied, including 
demographic and clinical variations. 
 
Researchers have previously investigated the relationship between CCT and self-
tonometry measurement error. Three previous reports observed increasing IOP 
differences with higher CCT using Icare One tonometry,[13, 14, 16] while another 
study found no relation between these variables.[15] Present study findings reveal 
greater underestimation of Icare Home self-readings compared with GAT for CCT 
outside the recommended range of 500 to 600µm. Our finding of a discrepancy 
between right and left eye measurements by Icare Home has not been previously 
reported. The greater underestimation of right eye IOP estimates was common to 
self-, partner- and trainer- observations.  In all instances, the right eye was measured 
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before the left, and the trainer/ partner remained on the same side of the subject 
during right and left eye assessment. One might expect higher IOP in the first eye 
measured as subjects are more likely to squeeze their eyes in apprehension leading 
to an artefactual rise in IOP. However, our results followed an opposite trend which 
may be explained by differences in positioning and angling of the probe relative to 
the central cornea between right and left eye assessment. [24] Interestingly, the 3 
left-handed individuals who reliably performed self-tonometry did not observe this 
trend, but the low number of subjects in this group precludes further analysis.  
 
It is estimated that 2 in 3 patients with systemic hypertension regularly practice home 
monitoring in developed countries.[25] More frequent self-monitoring of blood 
glucose levels has also been shown to provide better control of diabetes.[26] Over 
the years, a number of technologies have emerged to enable similar adoption of 
ocular pressure monitoring (e.g. contact lens telemetry), but none have been widely 
adopted for use in clinical practice. The introduction of self-tonometry may provide 
data on variability in IOP to assist both the diagnosis and management of the 
glaucomas. Being a portable device that does not require the use of anaesthesia, the 
Icare Home tonometer has potential for self-measurement and home monitoring. 
Present study findings show a small under-read compared with GAT which was, by 
and large, consistent across a wide range of IOPs, although reliability was limited to 
a CCT of 500-600µm. 
 
Strengths of this study include a wide IOP range for the comparison between Icare 
Home and GAT, and sampling of a predominantly elderly population with glaucoma/ 
OHT. This improves generalisability of the study findings to a population who are 
likely to benefit from self-tonometry in the future.  Conversely, the majority of 
subjects were highly motivated with self-interest in their eye condition, which may 
have lead to an overestimation in the proportion able to perform self-measurement.   
 
Overtime, advances in self-measurement technology are anticipated to further 
improve use-ability and measurement characteristics.  This report outlines initial 
findings that confirm the accuracy of Icare Home tonometry for self-assessment. 
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Work is currently ongoing to ascertain the feasibility of using the Icare Home for self-
measurement in a home setting.   
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Legends for display items (Figures) 
 
Figure 1:  Standardised training procedure for use of the Icare Home tonometer 
 
Figure 2:  Bland-Altman difference plots evaluating agreement between GAT and 
Icare Home tonometry for a) Self-measurement, b) Partner-measurement, illustrated 
with mean bias (dashed line) and 95% limits of agreement (dotted lines) 
